Staff Publications

Staff Publications

  • external user (warningwarning)
  • Log in as
  • language uk
  • About

    'Staff publications' is the digital repository of Wageningen University & Research

    'Staff publications' contains references to publications authored by Wageningen University staff from 1976 onward.

    Publications authored by the staff of the Research Institutes are available from 1995 onwards.

    Full text documents are added when available. The database is updated daily and currently holds about 240,000 items, of which 72,000 in open access.

    We have a manual that explains all the features 

Current refinement(s):

  • help
  • print

    Print search results

  • export

    Export search results

  • alert
    We will mail you new results for this query: keywords==subfraction
Check title to add to marked list
The effect of atorvastatin on serum lipide, lipoproteins and NMR-spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease
Soedamah-Muthu, S.S. ; Colhoun, H.M. ; Thomason, M.J. ; Betteridge, D.J. ; Durrington, P.N. ; Hitman, G.A. ; Fuller, J.H. ; Julier, K. ; Mackness, M.I. ; Neil, H.A.W. - \ 2003
Atherosclerosis 167 (2003)2. - ISSN 0021-9150 - p. 243 - 255.
familial combined hyperlipidemia - cholesteryl ester transfer - b-containing lipoproteins - coronary-artery-disease - triglyceride-rich lipoproteins - low-density lipoproteins - coa reductase inhibitor - simvastatin treatment - pravastatin treatment - subfraction
The effect of statin therapy on subclasses of LDL, VLDL and HDL lipoproteins is unclear. We compared changes in serum lipids, apolipoproteins and nuclear magnetic resonance (NMR) spectroscopy measured lipoprotein subclass concentration and average particle size over a minimum 6 months treatment period of atorvastatin 10 mg vs. placebo in 122 men and women. All subjects had type 2 diabetes and a modest dyslipidaemia (mean LDL-cholesterol 3.2 mmol/l and median triglycerides 1.8 mmol/l) and had a previous myocardial infarction. Compared with placebo, atorvastatin therapy was associated with a greater decrease in medium VLDL (median within person change -13.4 vs. -5.9 nmol/l, P
Check title to add to marked list

Show 20 50 100 records per page

 
Please log in to use this service. Login as Wageningen University & Research user or guest user in upper right hand corner of this page.